{"title":"急性前路心肌梗死患者接受链激酶溶栓治疗后中性粒细胞与淋巴细胞比值升高与住院预后的关系","authors":"Habib Ur Razaq, Dr Khurshid Ali, Aqsa","doi":"10.52206/jsmc.2022.12.2.694","DOIUrl":null,"url":null,"abstract":"Background: Myocardial infarction mainly contributes to morbidity and mortality around the globe. Thrombolytic therapy with streptokinase is the primary treatment strategy for patients with the presentation of ST-segment-elevated acute myocardial Infarction. Objective: To assess to assess the correlation between increased NLR and in-hospital outcome in acute anterior MI patients subjected to streptokinase therapy. Material and Methods: The study was a retrospective cohort conducted over a period of six months from 01, 06, 2021 to 30, 11, and 2021. All the patients admitted consecutively during this period received streptokinase therapy. The patients were grouped with respect to NLR, i.e., high NLR ang low NLR. The cut-off point for dividing into these two groups was set as 4.50 as an average of studies previously conducted. The study endpoints in-hospital outcomes and the secondary end point was short-term mortality.Results: A total of 250 patients were presented with acute MI. Complications were reported in 115 patients (46%) whereas 46 deaths (18.4%) were reported. More complications were reported in patients present in the group with higher NLR, (n=83 vs. 27, 62.8 % vs. 22.8 %, p <0.0001), as well as death (n=35 vs. 11, 26.5 % vs. 9.3 %, p<0.0001) in hospital compared to the group with lower NLR. Conclusion: high NLR (using 4.50 as cut-off value) is in association with a higher rate of complicatxions and death during stay in the hospital in acute MI patients which are subjected to streptokinase. Key Words: Myocardial infarction, Thrombolytic therapy, Streptokinase, Neutrophil, Lymphocyte.","PeriodicalId":326561,"journal":{"name":"Journal of Saidu Medical College, Swat","volume":"123 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of Increased Neutrophil to Lymphocyte Ratio to in-Hospital Outcome of Acute anterior Myocardial Infarction Patients Subjected to Thrombolytic Therapy with Streptokinase\",\"authors\":\"Habib Ur Razaq, Dr Khurshid Ali, Aqsa\",\"doi\":\"10.52206/jsmc.2022.12.2.694\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Myocardial infarction mainly contributes to morbidity and mortality around the globe. Thrombolytic therapy with streptokinase is the primary treatment strategy for patients with the presentation of ST-segment-elevated acute myocardial Infarction. Objective: To assess to assess the correlation between increased NLR and in-hospital outcome in acute anterior MI patients subjected to streptokinase therapy. Material and Methods: The study was a retrospective cohort conducted over a period of six months from 01, 06, 2021 to 30, 11, and 2021. All the patients admitted consecutively during this period received streptokinase therapy. The patients were grouped with respect to NLR, i.e., high NLR ang low NLR. The cut-off point for dividing into these two groups was set as 4.50 as an average of studies previously conducted. The study endpoints in-hospital outcomes and the secondary end point was short-term mortality.Results: A total of 250 patients were presented with acute MI. Complications were reported in 115 patients (46%) whereas 46 deaths (18.4%) were reported. More complications were reported in patients present in the group with higher NLR, (n=83 vs. 27, 62.8 % vs. 22.8 %, p <0.0001), as well as death (n=35 vs. 11, 26.5 % vs. 9.3 %, p<0.0001) in hospital compared to the group with lower NLR. Conclusion: high NLR (using 4.50 as cut-off value) is in association with a higher rate of complicatxions and death during stay in the hospital in acute MI patients which are subjected to streptokinase. Key Words: Myocardial infarction, Thrombolytic therapy, Streptokinase, Neutrophil, Lymphocyte.\",\"PeriodicalId\":326561,\"journal\":{\"name\":\"Journal of Saidu Medical College, Swat\",\"volume\":\"123 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Saidu Medical College, Swat\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52206/jsmc.2022.12.2.694\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Saidu Medical College, Swat","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52206/jsmc.2022.12.2.694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:心肌梗死是全球范围内发病率和死亡率的主要原因。链激酶溶栓治疗是st段抬高急性心肌梗死患者的主要治疗策略。目的:评价急性前路心肌梗死患者接受链激酶治疗后NLR升高与住院预后的相关性。材料和方法:该研究是一项回顾性队列研究,为期6个月,从2021年1月、6月到2021年30日、11日和2021年。在此期间连续入院的患者均接受链激酶治疗。患者根据NLR进行分组,即高NLR和低NLR。这两组的分界点被设定为4.50,这是之前进行的研究的平均值。研究终点是院内结局,次要终点是短期死亡率。结果:共有250例患者出现急性心肌梗死,其中115例(46%)出现并发症,46例(18.4%)死亡。与低NLR组相比,高NLR组的患者出现了更多的并发症(n=83 vs. 27,62.8% vs. 22.8%, p<0.0001),以及住院死亡(n=35 vs. 11,26.5% vs. 9.3%, p<0.0001)。结论:高NLR(以4.50作为临界值)与接受链激酶治疗的急性心肌梗死患者住院期间较高的并发症发生率和死亡率相关。关键词:心肌梗死,溶栓治疗,链激酶,中性粒细胞,淋巴细胞。
Association of Increased Neutrophil to Lymphocyte Ratio to in-Hospital Outcome of Acute anterior Myocardial Infarction Patients Subjected to Thrombolytic Therapy with Streptokinase
Background: Myocardial infarction mainly contributes to morbidity and mortality around the globe. Thrombolytic therapy with streptokinase is the primary treatment strategy for patients with the presentation of ST-segment-elevated acute myocardial Infarction. Objective: To assess to assess the correlation between increased NLR and in-hospital outcome in acute anterior MI patients subjected to streptokinase therapy. Material and Methods: The study was a retrospective cohort conducted over a period of six months from 01, 06, 2021 to 30, 11, and 2021. All the patients admitted consecutively during this period received streptokinase therapy. The patients were grouped with respect to NLR, i.e., high NLR ang low NLR. The cut-off point for dividing into these two groups was set as 4.50 as an average of studies previously conducted. The study endpoints in-hospital outcomes and the secondary end point was short-term mortality.Results: A total of 250 patients were presented with acute MI. Complications were reported in 115 patients (46%) whereas 46 deaths (18.4%) were reported. More complications were reported in patients present in the group with higher NLR, (n=83 vs. 27, 62.8 % vs. 22.8 %, p <0.0001), as well as death (n=35 vs. 11, 26.5 % vs. 9.3 %, p<0.0001) in hospital compared to the group with lower NLR. Conclusion: high NLR (using 4.50 as cut-off value) is in association with a higher rate of complicatxions and death during stay in the hospital in acute MI patients which are subjected to streptokinase. Key Words: Myocardial infarction, Thrombolytic therapy, Streptokinase, Neutrophil, Lymphocyte.